Unlike its multifaceted, even contradictory “dual-sided” regulatory patterns in tumor and fibroblast cells, CARM1 exhibits high specificity in skeletal muscle, precisely focusing its function on glycogen metabolism pathways. This evidence concerns the gene CARM1 and neoplasm.